Publicacións en colaboración con investigadores/as de Universidad de Salamanca (22)

2023

  1. Expert opinion paper on the treatment of hemophilia a with emicizumab

    Hematology (Amsterdam, Netherlands), Vol. 28, Núm. 1, pp. 2166334

  2. Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain

    European Journal of Haematology, Vol. 111, Núm. 3, pp. 485-490

2022

  1. Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

    Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270

2021

  1. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

    Blood, Vol. 137, Núm. 14, pp. 1879-1894

  2. Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial

    Blood Cancer Journal, Vol. 11, Núm. 5

2018

  1. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

    Haematologica, Vol. 103, Núm. 1, pp. 148-162

2013

  1. Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does -7/7q- detection by FISH have prognostic value?

    Leukemia Research, Vol. 37, Núm. 4, pp. 416-421

2012

  1. The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome

    PLoS ONE, Vol. 7, Núm. 8

2011

  1. Cell-cycle distribution of different cell compartments in normal versus reactive bone marrow: A frame of reference for the study of dysplastic hematopoiesis

    Cytometry Part B - Clinical Cytometry, Vol. 80 B, Núm. 6, pp. 354-361

2010

  1. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era

    European Journal of Haematology, Vol. 85, Núm. 4, pp. 321-328

2009

  1. Identification of leptomeningeal disease in aggressive B-Cell non-Hodgkin's lymphoma: Improved sensitivity of flow cytometry

    Journal of Clinical Oncology, Vol. 27, Núm. 9, pp. 1462-1469

  2. Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease

    International Journal of Cancer, Vol. 124, Núm. 2, pp. 367-375

1997

  1. Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients

    Hematology and Cell Therapy, Vol. 39, Núm. 5, pp. 223-227

  2. Síndrome de condensación anómala de la cromatina de los leucocitos con elevada fase de síntesis medular y crecimiento autónome in vitro

    Medicina Clinica, Vol. 109, Núm. 9, pp. 340-342

1987

  1. Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis.

    Thrombosis and haemostasis, Vol. 58, Núm. 2, pp. 753-757

  2. Assessment of Multimeric Structure and Ristocetin‐Induced Binding to Platelets of Von Willebrand Factor Present in Cryoprecipitate and Different Factor VIII Concentrates

    Vox Sanguinis, Vol. 52, Núm. 1-2, pp. 15-19

  3. Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals

    Blood, Vol. 70, Núm. 1, pp. 173-176

1986

  1. Platelet and plasma von willebrand factor: structural differences

    Thrombosis Research, Vol. 44, Núm. 1, pp. 125-128

  2. von willebrand disease type IIC with different abnormalities of von willebrand factor in the same sibship

    American Journal of Hematology, Vol. 21, Núm. 2, pp. 177-188

1983

  1. ELECTROBLOTTING OF FACTOR VIII/VON WILLEBRAND FACTOR MULTIMERS AFTER ELECTROPHORESIS IN SDS–AGAROSE GEL, DISCONTINUOUS BUFFER SYSTEM

    British Journal of Haematology, Vol. 55, Núm. 1, pp. 195-196